PQRI: Oncology measures see code changes for 2008

Why This Topic Matters

Healthcare organizations reporting oncology quality measures need to align their claims and documentation with the updated PQRI measure specifications. Understanding these changes helps avoid outdated reporting logic and supports accurate quality submission for cancer care services.

Article Sections

1. Overview of 2008 PQRI oncology measure changes

   Introduces the oncology-related PQRI measures affected by the 2008 update and summarizes the type of coding changes involved. It also distinguishes between updated quality reporting codes and unchanged underlying clinical coding references.

2. ER/PR Positive Breast Cancer: Tamoxifen or aromatase inhibitor therapy

   Covers the breast cancer quality measure, its reporting scenarios, and the associated staging and receptor-status documentation categories. The section presents the revised quality reporting structure for this measure.

3. Colon Cancer: Chemotherapy for Stage III

   Summarizes the colon cancer chemotherapy quality measure and the documentation scenarios tied to stage-based reporting. It highlights the measure’s updated quality code structure for 2008.

4. Chemotherapy Plan: Plan documented before chemotherapy administration

   Describes the chemotherapy planning measure used for patients receiving chemotherapy and the related documentation category. The section notes the reporting framework used for plan documentation.